Remus Pharmaceuticals (NSE:REMUS) Buildings And Improvements : ₹0 Mil (As of Mar. 2025)

View and export this data going back to 2023. Start your Free Trial

What is Remus Pharmaceuticals Buildings And Improvements?

Remus Pharmaceuticals's quarterly buildings and improvements declined from Mar. 2024 (₹3 Mil) to Sep. 2024 (₹0 Mil) but then stayed the same from Sep. 2024 (₹0 Mil) to Mar. 2025 (₹0 Mil).

Remus Pharmaceuticals's annual buildings and improvements increased from Mar. 2022 (₹0 Mil) to Mar. 2024 (₹3 Mil) but then declined from Mar. 2024 (₹3 Mil) to Mar. 2025 (₹0 Mil).

Remus Pharmaceuticals Buildings And Improvements Historical Data

The historical data trend for Remus Pharmaceuticals's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Remus Pharmaceuticals Buildings And Improvements Chart

Remus Pharmaceuticals Annual Data

Trend

Mar20

Mar21

Mar22

Mar24

Mar25

Buildings And Improvements

3.28

Remus Pharmaceuticals Semi-Annual Data
	Mar20	Mar21	Mar22	Sep23	Mar24	Sep24	Mar25
Buildings And Improvements	Get a 7-Day Free Trial			-	-	3.28	-	-

Remus Pharmaceuticals Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

Remus Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Remus Pharmaceuticals Ltd (NSE:REMUS) » Definitions » Buildings And Improvements

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ambli bopal Road, 1101 to 1103, South Tower, One 42, Behind Ashok Vatika, Near Jayantilal Park BRTS, Ahmedabad, GJ, IND, 380054

Website

https://www.remuspharma.com

Remus Pharmaceuticals Ltd is engaged in the marketing & distribution of finished formulations of pharmaceutical drugs. The company also deals in API (Active Pharmaceutical Ingredient). It also provides technical consultancy services to various distributors for the preparation of reports on the dossiers of the products to be registered by them in various countries. Remus Pharmaceuticals market niche medicinal combinations. It exports generic drugs by conducting intensive market research in the pharmaceutical industry to expand its product portfolio.

Remus Pharmaceuticals Headlines

No Headlines